Search – Page 85 – Indianapolis Business Journal

Home » Search

Articles

Not-for-profits’ latest strategy: junior boards

December 16, 2016

Young professional boards, usually consisting of members ages 21 to 40, vary in size and responsibilities, but the groups are seen as a way to engage millennials.

Lilly shares jump after it offers better-than-expected forecast

December 15, 2016

Eli Lilly and Co. shares rose sharply Thursday morning after the company presented a better-than-expected 2017 forecast nearly a month after it had announced the failure of a key Alzheimer’s treatment in testing.

Lilly trims profit guidance but says growth strategy on track

December 15, 2016

The company’s announcement reassured investors in the wake of last month’s news that the Alzheimer’s drug solanezumab had failed to demonstrate effectiveness during a large-scale clinical trial.

My body is the battleground between cancer and chemo

December 14, 2016 | John Russell

The point of chemo is to cure me. But these are not gentle chemicals. They sweep through my body like a tornado, with side effects that range from annoying to horrendous. But I have no choice.

Lilly to sell insulin at 40 percent discount to cash-paying patients

December 14, 2016

Eli Lilly and Co. will bypass insurance companies to offer a discount on its best-selling insulin products for patients who lack health coverage or have high deductibles that require them to pay the full cost of some medications.

Lilly partners with AstraZeneca on another Alzheimer’s treatment

December 9, 2016

The Indianapolis-based company, which last month struck out in a late-stage clinical trial for a potential Alzheimer’s drug called solanezumab, announced Friday a collaboration with AstraZeneca to develop another possible treatment for the mind-robbing disease.

IMA plans to restore damaged ‘LOVE’ sculpture, move it inside

December 8, 2016

The move means people must pay museum entry fees to see the iconic sculpture, which was artist Robert Indiana’s first in a series of “LOVE” works.

PETERSON: A Dem’s advice for our new GOP governor

December 8, 2016

Taking office without a plan is like trying to cross the Atlantic in a small boat without navigation equipment.

Lilly threatens Sanofi’s dominance in insulin with knockoff drug

December 7, 2016

In a few days, a new type of knockoff medicine will upend a $10 billion diabetes-drug market and exacerbate a brutal price war between some of its biggest players.

After rough November, some good news for Lilly

December 5, 2016

The FDA says the Indianapolis-based drugmaker and its partner can make an important label claim on its new diabetes drug—a move analysts say could give sales a big boost.

Lilly competitor to cap price increases as drug costs face more scrutiny

December 5, 2016

With drug companies under fire, the world’s largest insulin maker plans to limit price increases and introducing a model that ties the cost of medicines to the results they deliver.

Lilly to lay off hundreds after failure of Alzheimer’s drug

December 2, 2016

Eli Lilly and Co. plans to lay off hundreds of U.S. sales representatives in coming months, following the disappointing failure of an experimental drug for Alzheimer’s disease announced last week.

At Eli Lilly, tears, heartbreak and renewed determination

December 1, 2016

Eli Lilly and Co. employees knew the Alzheimer's treatment solanezumab was not a sure bet. But that didn’t make the pain any less acute after the company announced the drug had failed to demonstrate effectiveness during a 2,100-patient Phase 3 clinical trial.

« Previous 1 … 83 84 85 86 87 … 221 Next »

Search Results

4,410 results for '\"eli lilly\"'

Articles

Not-for-profits’ latest strategy: junior boards

Lilly shares jump after it offers better-than-expected forecast

Lilly trims profit guidance but says growth strategy on track

My body is the battleground between cancer and chemo

Lilly to sell insulin at 40 percent discount to cash-paying patients

Lilly partners with AstraZeneca on another Alzheimer’s treatment

IMA plans to restore damaged ‘LOVE’ sculpture, move it inside

PETERSON: A Dem’s advice for our new GOP governor

Lilly threatens Sanofi’s dominance in insulin with knockoff drug

After rough November, some good news for Lilly

Lilly competitor to cap price increases as drug costs face more scrutiny

Lilly to lay off hundreds after failure of Alzheimer’s drug

At Eli Lilly, tears, heartbreak and renewed determination

‘Flexible’ lease space for tech firms to open downtown next year

Buy, sell or hold after Lilly’s Alzheimer’s flop?

Holcomb to lead Indiana delegation to United Kingdom

Expanding pre-K takes more than money

Failure of Lilly’s Alzheimer’s drug not a big surprise to analysts

Lilly’s Alzheimer’s disease drug fails in final-stage trial

Lilly CEO: Find overlap between corporate mission, philanthropy